Pyridostigmine-Induced Status Epilepticus Rat Model Was Resistant to Increasing Doses of Ramipril: The Latter Triggered Epileptogenesis, Arrhythmia, and Cardiac Ischemia in a Dose-Dependent Manner

Main Article Content

Sherine Abdelmissih
Monica Gamal
Kerollos M Naeem

Abstract

Background: Studies explored the therapeutic role of agents inhibiting RAS in epilepsy. Fewer studies addressed the electrophysiological changes associated with angiotensin converting enzyme inhibitors (ACEIs) in terms of sustained seizures (status epilepticus). Sodium valproate (SVPA), a broad-spectrum anticonvulsant, has been associated with adverse cardiac events upon long-term use, in contrast to the beneficial role of ACEIs in cardiovascular disorders. This work explored the potential effects of ramipril, an ACEI, compared to SVPA, on the behavior, and electrophysiology of the brain and heart in a rat model of status epilepticus. The dose dependent pattern of the presumed ramipril activities was investigated.


Methods: Adult male rats were assigned into seven groups, controls, IP pyridostigmine (36 mg/kg)-induced status epilepticus (PISE), oral SVPA (5 mg/kg), and three groups receiving oral ramipril at respective doses of 5 (R5), 10 (R10), and 20 mg/kg (R20). Rat behavior was assessed using Racine’s motor convulsion scoring for 10 minutes. Blood pressure was recorded, and electroencephalography (EEG) and electrocardiography (ECG) were performed on the sedated rats 24 hours after recovery.


Results: Despite the partial behavioral improvement of motor convulsions with R5 and R10 exhibited epileptogenic activity, as indicated by the increased relative power of fast and slow gamma waves and total EEG power. R10 triggered arrhythmia and cardiac ischemia as indicated by absence of P wave, along with ST elevation and tall T wave, slowed heart rate and prolonged QRS, QTc, and RR intervals.


Conclusion: PISE was resistant to sodium valproate and ramipril. Ramipril at low and moderate doses induced epileptogenic activity and, especially at moderate dose, precipitated cardiac ischemia and arrhythmia.


Summary
The debatable role of ramipril in epilepsy was studied in a rat model of pyridostigmine-induced status epilepticus, compared to sodium valproate. Increasing ramipril doses did not resolve status epilepticus in rats. Instead, low and moderate doses exhibited epileptogenic activity, opposite to high dose ramipril and sodium valproate. Blood pressure was dose-dependently reduced with ramipril. Electrocardiography showed evidence of cardiac arrythmia and ischemia, especially with the moderate ramipril dose. The behavioral and EEG indices correlated with systolic blood pressure and ECG changes.

Article Details

Abdelmissih, S., Gamal, M., & Naeem, K. M. (2025). Pyridostigmine-Induced Status Epilepticus Rat Model Was Resistant to Increasing Doses of Ramipril: The Latter Triggered Epileptogenesis, Arrhythmia, and Cardiac Ischemia in a Dose-Dependent Manner. Journal of Neuroscience and Neurological Disorders, 9(1), 010–027. https://doi.org/10.29328/journal.jnnd.1001106
Research Articles

Copyright (c) 2025 Abdelmissih S, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

World Health Organization. Epilepsy 2024 [updated 7 February 2024; cited 2024 8 July]. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy

Vezzani A, Scharfman HE. Epileptogenesis. In: Jasper's Basic Mechanisms of the Epilepsies. 5th ed. Oxford University Press; 2024.

Xu C, Wang Y, Chen Z. Novel mechanism, drug target and therapy in epilepsy. Neurosci Bull. 2024;40(5):561-3. Available from: https://doi.org/10.1007/s12264-024-01215-0

Dirican AC, Mutluay B, Eren F, Ataklı HD. Importance of long-term EEG in seizure-free patients with normal routine EEG. Arch Epilepsy. 2023;29(3):91-5. Available from: https://archepilepsy.org/articles/importance-of-long-term-eeg-in-seizure-free-patients-with-normal-routine-eeg/doi/ArchEpilepsy.2023.23078

Janiukstyte V, Owen TW, Chaudhary UJ, Diehl B, Lemieux L, Duncan JS, et al. Normative brain mapping using scalp EEG and potential clinical application. Sci Rep. 2023;13(1):13442. Available from: https://www.nature.com/articles/s41598-023-39700-7

Vorderwülbecke BJ, Wandschneider B, Weber Y, Holtkamp M. Genetic generalized epilepsies in adults—challenging assumptions and dogmas. Nat Rev Neurol. 2022;18(2):71-83. Available from: https://doi.org/10.1038/s41582-021-00583-9

Sirven JI. Evaluation and management of drug-resistant epilepsy 2024 [updated 19 December 2023; cited 2024 8 July]. Available from: https://www.uptodate.com/contents/evaluation-and-management-of-drug-resistant-epilepsy

Trinka E, Leitinger M. Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum (Minneap Minn). 2022;28(2):559-602. Available from: https://doi.org/10.1212/con.0000000000001103

Ramos AJ. Brain angiotensin system: a new promise in the management of epilepsy? Clin Sci (Lond). 2021;135(6):725-30. Available from: https://doi.org/10.1042/cs20201296

Chang KC, Lin CH, Huang JA. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers is associated with a reduced risk of poststroke epilepsy in patients with ischemic stroke. J Am Heart Assoc. 2024;13(17):e035438. Available from: https://doi.org/10.1161/jaha.124.035438

Rusek M, Czuczwar SJ. A review of clinically significant drug-drug interactions involving angiotensin II receptor antagonists and antiepileptic drugs. Expert Opin Drug Metab Toxicol. 2020;16(6):507-15. Available from: https://doi.org/10.1080/17425255.2020.1763955

Rathi V, Sagi SS, Yadav AK, Kumar M, Varshney R. Quercetin prophylaxis protects the kidneys by modulating the renin-angiotensin-aldosterone axis under acute hypobaric hypoxic stress. Sci Rep. 2024;14(1):7617. Available from: https://doi.org/10.1038/s41598-024-58134-3

Booker HE, Goodfriend TL, Tewksbury DA. Plasma renin concentration and phenobarbital levels in patients with epilepsy. Clin Pharmacol Ther. 1979;26(6):715-7. Available from: https://doi.org/10.1002/cpt1979266715

Saavedra JM, Armando I, Bregonzio C, Juorio A, Macova M, Pavel J, et al. A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology. 2006;31(6):1123-34. Available from: https://doi.org/10.1038/sj.npp.1300921

Almeida SS, Naffah-Mazzacoratti MdG, Guimarães PB, Wasinski F, Pereira FEG, Canzian M, et al. Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy. Transl Psychiatry. 2012;2(3):e93. Available from: https://doi.org/10.1038/tp.2012.21

Łukawski K, Czuczwar SJ. Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it. Expert Opin Drug Metab Toxicol. 2021;17(9):1075-90. Available from: https://doi.org/10.1080/17425255.2021.1959912

Łukawski K, Raszewski G, Czuczwar SJ. Interactions of aliskiren, a direct renin inhibitor, with antiepileptic drugs in the test of maximal electroshock in mice. Eur J Pharmacol. 2018;819:108-13. Available from: https://doi.org/10.1016/j.ejphar.2017.11.037

Atanasova D, Tchekalarova J, Ivanova N, Nenchovska Z, Pavlova E, Atanassova N, et al. Losartan suppresses the kainate-induced changes of angiotensin AT1 receptor expression in a model of comorbid hypertension and epilepsy. Life Sci. 2018;193:40-6. Available from: https://doi.org/10.1016/j.lfs.2017.12.006

Ivanova N, Tchekalarova J. The potential therapeutic capacity of inhibiting the brain renin-angiotensin system in the treatment of co-morbid conditions in epilepsy. CNS Drugs. 2019;33(11):1101-12. Available from: https://doi.org/10.1007/s40263-019-00678-4

Subramanian D, Ayus JC. Case report: severe symptomatic hyponatremia associated with lisinopril therapy. Am J Med Sci. 1992;303(3):177-9. Available from: https://doi.org/10.1097/00000441-199203000-00009

De Sarro G, Di Paola ED, Gratteri S, Gareri P, Rispoli V, Siniscalchi A, et al. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res. 2012;65(3):285-96. Available from: https://doi.org/10.1016/j.phrs.2011.11.005

Tastemur Y, Gumus E, Ergul M, Ulu M, Akkaya R, Ozturk A, et al. Positive effects of angiotensin-converting enzyme (ACE) inhibitor, captopril, on pentylenetetrazole-induced epileptic seizures in mice. Trop J Pharm Res. 2020;19(3):637-43. Available from: http://dx.doi.org/10.4314/tjpr.v19i3.26

Fialho GL, Miotto R, Cavagnollo MT, Melo HM, Wolf P, Walz R, et al. The epileptic heart: Cardiac comorbidities and complications of epilepsy. Atrial and ventricular structure and function by echocardiography in individuals with epilepsy–From clinical implications to individualized assessment. Epilepsy Behav Rep. 2024:100668. Available from: https://doi.org/10.1016/j.ebr.2024.100668

Liu Z, Thergarajan P, Antonic‐Baker A, Chen Z, Sparks PB, Lannin NA, et al. Cardiac structural and functional abnormalities in epilepsy: A systematic review and meta‐analysis. Epilepsia Open. 2023;8(1):46-59. Available from: https://doi.org/10.1002/epi4.12692

Ha FJ, Chong T, Cook MJ, Paratz ED. Epilepsy and cardiac arrhythmias: a state-of-the-art review. Clin Electrophysiol. 2025;11(1):217-29. Available from: https://doi.org/10.1016/j.jacep.2024.09.034

Mazzola L, Mauguière F, Chouchou F. Central control of cardiac activity as assessed by intra-cerebral recordings and stimulations. Neurophysiol Clin. 2023;53(2):102849. Available from: https://doi.org/10.1016/j.neucli.2023.102849

Rossi KC, Gursky JM, Pang TD, Dhamoon MS. Seizures and status epilepticus may be risk factor for cardiac arrhythmia or cardiac arrest across multiple time frames. Epilepsy Behav. 2021;120:107998. Available from: https://doi.org/10.1016/j.yebeh.2021.107998

Rugg-Gunn FJ, Simister RJ, Squirrell M, Holdright DR, Duncan JS. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet. 2004;364(9452):2212-9. Available from: https://doi.org/10.1016/s0140-6736(04)17594-6

Zheng Z, Chen H, Chen Y, Tan X. Causal association between epilepsy and its DNA methylation profile and atrial fibrillation. Heart Rhythm. 2024. Available from: https://doi.org/10.1016/j.hrthm.2024.09.008

Wang J, Huang P, Yu Q, Lu J, Liu P, Yang Y, et al. Epilepsy and long-term risk of arrhythmias. Eur Heart J. 2023;44(35):3374-82. Available from: https://doi.org/10.1093/eurheartj/ehad523

Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A, et al. Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia. 2019;60(1):53-62. Available from: https://doi.org/10.1111/epi.14607

Giussani G, Falcicchio G, La Neve A, Costagliola G, Striano P, Scarabello A, et al. Sudden unexpected death in epilepsy: A critical view of the literature. Epilepsia Open. 2023;8(3):728-57. Available from: https://doi.org/10.1002/epi4.12722

Bardai A, Blom MT, Van Noord C, Verhamme KM, Sturkenboom MC, Tan HL. Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart. 2015;101(1):17-22. Available from: https://doi.org/10.1136/heartjnl-2014-305664

Vitorović-Todorović MD, Vujatović-Velimirov T. The reversible inhibitors of acetylcholinesterase as pretreatment options against nerve agents’ intoxications. In: Sensing of Deadly Toxic Chemical Warfare Agents, Nerve Agent Simulants, and their Toxicological Aspects. 2023:503-28. Available from: https://doi.org/10.1016/B978-0-323-90553-4.00010-X

Herkert N, Thiermann H, Worek F. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species. Toxicol Lett. 2011;206(1):41-6. Available from: https://doi.org/10.1016/j.toxlet.2011.03.004

Wu P, Hong S, Zhong M, Guo Y, Chen H, Jiang L. Effect of sodium valproate on cognitive function and hippocampus of rats after convulsive status epilepticus. Med Sci Monit. 2016;22:5197. Available from: https://doi.org/10.12659/msm.898859

Vittalrao AM, KG MR. Cognitive enhancing activities of coenzyme Q10, ramipril, and vinpocetine through modulating neuroinflammatory response and oxidative damage inflicted by acute REM sleep deprivation in rats. Biomed Pharmacol J. 2023;16(4):2021-30. Available from: https://dx.doi.org/10.13005/bpj/2778

Romoli M, Mazzocchetti P, D'Alonzo R, Siliquini S, Rinaldi VE, Verrotti A, et al. Valproic acid and epilepsy: from molecular mechanisms to clinical evidences. Curr Neuropharmacol. 2019;17(10):926-46. Available from: https://doi.org/10.2174/1570159x17666181227165722

Walton NY, Treiman DM. Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice. Neurology. 1990;40(6):990-4. Available from: https://doi.org/10.1212/wnl.40.6.990

Carpenter's exotic animal formulary. 6th ed: Elsevier; 2022 19 August 2022.

Patel S, Meldrum BS, Fine A. Susceptibility to pilocarpine-induced seizures in rats increases with age. Behav Brain Res. 1988;31(2):165-7. Available from: https://doi.org/10.1016/0166-4328(88)90019-8

Abdelmissih S, Abdelgwad M, Ali DME, Negm MSI, Eshra MA, Youssef A. High-dose Agomelatine Combined with Haloperidol Decanoate Improves Cognition, Downregulates MT2, Upregulates D5, and Maintains Krüppel-like Factor 9 But Alters Cardiac Electrophysiology. J Pharmacol Exp Ther. 2024;390(1):125-45. Available from: https://doi.org/10.1124/jpet.123.002087

University UfLAM-M. Guidelines on anesthesia and analgesia in rats 2023 [cited 2024 12 July 2024]. Available from: https://az.research.umich.edu/animalcare/guidelines/guidelines-anesthesia-and-analgesia-rats

Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19(2):69-73. Available from: https://doi.org/10.1016/j.seizure.2009.11.005

Silberman JT, TA. Carbamate toxicity 2024 22 July 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482183/

Skiba A, Kozioł E, Luca SV, Budzyńska B, Podlasz P, Van Der Ent W, et al. Evaluation of the Antiseizure Activity of Endemic Plant Halfordia kendack Guillaumin and Its Main Constituent, Halfordin, on a Zebrafish Pentylenetetrazole (PTZ)-Induced Seizure Model. Int J Mol Sci. 2023;24(3):2598. Available from: https://doi.org/10.3390/ijms24032598

Kasap Acungil Z, Tayhan SE, Tosun NG, Nacar T. The interactions of resveratrol and sodium valproate on penicillin-induced epilepsy model: electrophysiological and molecular study. Mol Neurobiol. 2024:1-11. Available from: https://doi.org/10.1007/s12035-024-04502-z

Ji Z-Y, Huang Y-Q, He W-Z. Sodium valproate combined with topiramate vs. sodium valproate alone for refractory epilepsy: a systematic review and meta-analysis. Front Neurol. 2022;12:794856. Available from: https://doi.org/10.3389/fneur.2021.794856

Chaney LA, Rockhold RW, Wineman RW, Hume AS. Anticonvulsant-resistant seizures following pyridostigmine bromide (PB) and N, N-diethyl-m-toluamide (DEET). Toxicol Sci. 1999;49(2):306-11. Available from: https://doi.org/10.1093/toxsci/49.2.306

Tchekalarova J, Georgiev V. Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? Life Sci. 2005;76(9):955-70. Available from: https://doi.org/10.1016/j.lfs.2004.10.012

Nguyen P, Brewster AL. Who Dunnit? Angiotensin, Inflammation, or Complement: Unresolved. Epilepsy Curr. 2023;23(2):133-5. Available from: https://doi.org/10.1177/15357597221150057

Dong X, Fan J, Lin D, Wang X, Kuang H, Gong L, et al. Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis. J Neuroinflammation. 2022;19(1):226. Available from: https://doi.org/10.1186/s12974-022-02587-8

Minano F, Serrano J, Sancibrian M, Serrano M. Effect of peptidyl‐dipeptidase inhibitors in experimental convulsions in mice. Fundam Clin Pharmacol. 1987;1(2):77-83. Available from: https://doi.org/10.1111/j.1472-8206.1987.tb00547.x

Sowden N, Booth C, Kaye G. Syncope, epilepsy and ictal asystole: a case series and narrative review. Heart Lung Circ. 2022;31(1):25-31. Available from: https://doi.org/10.1016/j.hlc.2021.07.003

Clemens B. Valproate decreases EEG synchronization in a use-dependent manner in idiopathic generalized epilepsy. Seizure. 2008;17(3):224-33. Available from: https://doi.org/10.1016/j.seizure.2007.07.005

Ibrahim MS, Kamat SR, Shamsuddin S. The role of brain wave activity by electroencephalogram (EEG) in assessing cognitive skills as an indicator for driving fatigue: A review. Malaysian J Compos Sci Manuf. 2023;11(1):19-31. Available from: https://akademiabaru.com/submit/index.php/mjcsm/article/view/4723

Lewis C, Deshpande A, Tesar GE, Dale R. Valproate-induced hyperammonemic encephalopathy: a brief review. Curr Med Res Opin. 2012;28(6):1039-42. Available from: https://doi.org/10.1185/03007995.2012.694362

Puris E, Fricker G, Gynther M. Targeting transporters for drug delivery to the brain: can we do better? Pharm Res. 2022;39(7):1415-55. Available from: https://doi.org/10.1007/s11095-022-03241-x

Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood–brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8(1):217. Available from: https://doi.org/10.1038/s41392-023-01481-w

Chvojka J. The Significance of High-Frequency Oscillations in Understanding Ictogenesis and Functional Organization of Epileptogenic Tissue: Czech Technical University; 2024.

Sato Y, Tsuji Y, Yamazaki M, Fujii Y, Shirasawa A, Harada K, et al. Interictal high gamma oscillation regularity as a marker for presurgical epileptogenic zone localization. Oper Neurosurg. 2022;23(2):164-73. Available from: https://doi.org/10.1227/ons.0000000000000245

Shi W, Shaw D, Walsh KG, Han X, Eden UT, Richardson RM, et al. Spike ripples localize the epileptogenic zone best: an international intracranial study. Brain. 2024;147(7):2496-506. Available from: https://doi.org/10.1093/brain/awae037

De Stefano P, Carboni M, Marquis R, Spinelli L, Seeck M, Vulliemoz S. Increased delta power as a scalp marker of epileptic activity: a simultaneous scalp and intracranial electroencephalography study. Eur J Neurol. 2022;29(1):26-35. Available from: https://doi.org/10.1111/ene.15106

Benbadis S, Beniczky S, Bertram E, MacIver S, Moshé SL. The role of EEG in patients with suspected epilepsy. Epileptic Disord. 2020;22(2):143-55. Available from: https://doi.org/10.1684/epd.2020.1151

Pottkämper JC, Verdijk JP, Stuiver S, Aalbregt E, Schmettow M, Hofmeijer J, et al. Seizure duration predicts postictal electroencephalographic recovery after electroconvulsive therapy-induced seizures. Clin Neurophysiol. 2023;148:1-8. Available from: https://doi.org/10.1016/j.clinph.2023.01.008

Chauhan M, PJ, Ahmad F. Ramipril 2024 06 December 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/30725804/

Lundqvist M, Miller EK, Nordmark J, Liljefors J, Herman P. Beta: bursts of cognition. Trends Cogn Sci. 2024;28(7):662-676. Available from: https://doi.org/10.1016/j.tics.2024.03.010

VanRullen R, Koch C. Competition and selection during visual processing of natural scenes and objects. J Vis. 2003;3(1):75-85. Available from: https://doi.org/10.1167/3.1.8

Tan E, Troller-Renfree SV, Morales S, Buzzell GA, McSweeney M, Antúnez M, et al. Theta activity and cognitive functioning: Integrating evidence from resting-state and task-related developmental electroencephalography (EEG) research. Dev Cogn Neurosci. 2024;67:101404. Available from: https://doi.org/10.1016/j.dcn.2024.101404

Yang W, Luo H, Ma Y, Si S, Zhao H. Effects of antihypertensive drugs on cognitive function in elderly patients with hypertension: a review. Aging Dis. 2021;12(3):841-851. Available from: https://doi.org/10.14336/ad.2020.1111

Dobrowolski C, Barraclough M, Su J, Tanic M, Bingham K, Ruttan L, et al. Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE. Lupus Sci Med. 2023;10(2):e000923. Available from: https://doi.org/10.1136/lupus-2023-000923

Caravaglios G, Muscoso E, Blandino V, Di Maria G, Gangitano M, Graziano F, et al. EEG resting-state functional networks in amnestic mild cognitive impairment. Clin EEG Neurosci. 2023;54(1):36-50. Available from: https://doi.org/10.1177/15500594221110036

Martin T, Kero K, Požar R, Giordani B, Kavcic V. Mild cognitive impairment in African Americans is associated with differences in EEG theta/beta ratio. J Alzheimers Dis. 2023;94(1):347-57. Available from: https://doi.org/10.3233/jad-220981

Villacres JE, Riveira N, Kim S, Colgin LL, Noebels JL, Lopez AY. Abnormal patterns of sleep and waking behaviors are accompanied by neocortical oscillation disturbances in an Ank3 mouse model of epilepsy-bipolar disorder comorbidity. Transl Psychiatry. 2023;13(1):403. Available from: https://doi.org/10.1038/s41398-023-02700-2

Ricci L, Assenza G, Pulitano P, Simonelli V, Vollero L, Lanzone J, et al. Measuring the effects of first antiepileptic medication in Temporal Lobe Epilepsy: Predictive value of quantitative-EEG analysis. Clin Neurophysiol. 2021;132(1):25-35. Available from: https://doi.org/10.1016/j.clinph.2020.10.020

Cuesta P, Ochoa-Urrea M, Funke M, Hasan O, Zhu P, Marcos A, et al. Gamma band functional connectivity reduction in patients with amnestic mild cognitive impairment and epileptiform activity. Brain Commun. 2022;4(2):fcac012. Available from: https://doi.org/10.1093/braincomms/fcac012

Akyüz E, Üner AK, Köklü B, Arulsamy A, Shaikh MF. Cardiorespiratory findings in epilepsy: A recent review on outcomes and pathophysiology. J Neurosci Res. 2021;99(9):2059-73. Available from: https://doi.org/10.1002/jnr.24861

Tavares R, Corrêa FMdA, Resstel L. Opposite role of infralimbic and prelimbic cortex in the tachycardiac response evoked by acute restraint stress in rats. J Neurosci Res. 2009;87(11):2601-7. Available from: https://doi.org/10.1002/jnr.22070

Abaseynejad F, Akrami R, Mohebbati R, Sehab Negah S, Mohammad-Zadeh M. The effect of sodium valproate on cardiovascular responses in pentylenetetrazol kindling model of epilepsy. Biomed J Sci Tech Res. 2022;42:33592-6. Available from: https://biomedres.us/fulltexts/BJSTR.MS.ID.006746.php

Jia L, Verkerk AO, Tan HL. The anti-epileptic drugs lamotrigine and valproic acid reduce the cardiac sodium current. Biomedicines. 2023;11(2):477. Available from: https://doi.org/10.3390/biomedicines11020477

Radgoudarzi M, Vafaee-Shahi M, Naderi F. Effect of sodium valproate treatment on the cardiac index in new cases with status epilepticus. Open Neurol J. 2021;15(1):59-64. Available from: https://doi.org/10.2174/1874205X02115010059

Kamani A, Omidi H, Dorreh F, Shariatmadari F, Ghandi Y. Effect of sodium valproate on cardiac function in epileptic children by tissue doppler echocardiography. Acta Med Iran. 2020:472-8. Available from: https://acta.tums.ac.ir/index.php/acta/article/view/8342

Wu Y, Yang X, Jing J, Meng X, Li Z, Pan Y, et al. Prognostic significance of atrial cardiopathy in patients with acute ischemic stroke. Eur Stroke J. 2023;8(1):183-90. Available from: https://doi.org/10.1177/23969873221126000

Schröder LC, Holkeri A, Eranti A, Haukilahti MAE, Kerola T, Kenttä TV, et al. Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with coronary artery disease. Heart Rhythm. 2022;19(6):952-9. Available from: https://doi.org/10.1016/j.hrthm.2022.02.010

Verrier RL, Pang TD, Nearing BD, Schachter SC. Epileptic heart: a clinical syndromic approach. Epilepsia. 2021;62(8):1780-9. Available from: https://doi.org/10.1111/epi.16966

Sasaki R, Osugi N, Nakagawa I. Generalized epilepsy with repetitive sinus pauses following generalized tonic-clonic seizures due to reduced baroreflex sensitivity. Cureus. 2023;15(5):e39392. Available from: https://doi.org/10.7759/cureus.39392

Patel N, Majeed F, Sule AA. Seizure triggered by sick sinus syndrome. Case Rep. 2017;2017:bcr-2017-222011. Available from: https://doi.org/10.1136/bcr-2017-222011

Arens AM, Kearney T. Adverse effects of physostigmine. J Med Toxicol. 2019;15:184-91. Available from: https://doi.org/10.1007/s13181-019-00697-z

Yousif R, Abdulghani MO, Gaber A, El Khayat N, Abo Elnaga Y, Wahid El Din MM. Frequency of peri-ictal apnea and cardiac arrhythmias in epileptic seizures. Egypt J Neurol Psychiatry Neurosurg. 2021;57:1-8. Available from: https://ejnpn.springeropen.com/articles/10.1186/s41983-021-00295-3

Ouchida S, Parratt K, Nikpour A, Fairbrother G. Syncope vs. Seizure: Ictal Bradycardia and Ictal Asystole. Case Rep Neurol Med. 2024;2024(1):1299282. Available from: https://doi.org/10.1155/2024/1299282

Stöllberger C, Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res. 2004;59(1):51-60. Available from: https://doi.org/10.1016/j.eplepsyres.2004.03.008

Geersing PG, Bulte CS, Viersen VA, Stek ML, Bouwman RA, Boer C, et al. Beat-to-beat hemodynamic monitoring during electroconvulsive therapy. J ECT. 2011;27(3):189-91. Available from: https://doi.org/10.1097/yct.0b013e3182008de5

Novak A, Vizjak K, Rakusa M. Cognitive impairment in people with epilepsy. J Clin Med. 2022;11(1):267. Available from: https://doi.org/10.3390/jcm11010267

Sayed NM, Aldin MTK, Ali SE, Hendi AE. Cognitive functions and epilepsy-related characteristics in patients with generalized tonic–clonic epilepsy: a cross-sectional study. Middle East Curr Psychiatry. 2023;30(1):15. Available from: https://mecp.springeropen.com/articles/10.1186/s43045-023-00293-6